Search for: "Insys"
Results 1 - 20
of 120
Sort by Relevance
|
Sort by Date
22 Aug 2023, 5:35 am
Insys Liquidation Trust v John N Kapoor, case no 1:21-ap-50557 in the US Bankruptcy Court for the District of Delaware [read post]
31 May 2023, 11:24 am
Insys Therapeutics, No. 2:16-cv-7937-JLS-AS (C.D. [read post]
4 Sep 2022, 1:34 am
$14 million from previous settlements with Insys CEO John Kapoor and McKinsey & Co. have also already been allocated to programs across the Departments of Health, Children and Families, Law and Public Safety, and Corrections to help combat the opioid epidemic as well. [read post]
29 Jul 2022, 3:33 pm
In stark contrast to the Purdue saga, at least a dozen Insys employees were criminally prosecuted by the DOJ for Insys’ multiple criminal conspiracies to unlawfully flood the market with an extremely potent liquid fentanyl spray called Subsys. [read post]
24 Jun 2022, 5:32 am
Insys executives claim they did not have medical knowledge of the dangerous effects of Subsys. [read post]
23 Jun 2022, 12:57 pm
In less than three years, Insys paid him over $278,000. [read post]
14 Jun 2022, 12:26 pm
The Boston Healthcare Fraud group made headlines for prosecuting the executives of Insys Therapeutics, which made Subsys, a fentanyl-based pain medication. [read post]
14 Jun 2022, 7:08 am
Kapoor, the founder of Insys Therapeutics, was found guilt of racketeering. [read post]
7 Jun 2022, 5:25 pm
John Kapoor was the executive chairman and Sunrise Lee a regional sales manager of Insys, a pharmaceutical company that sold a fentanyl spray developed to treat spikes in pain by chronic pain sufferers. [read post]
6 Jan 2022, 2:26 pm
The conviction of Insys Therapeutics, its principals, and the creative use of the RICO statute in a pharmaceutical criminal trial involving addicting opioids. [read post]
9 Nov 2021, 2:54 pm
Prior authorization requirements are a common hurdle to increased drug sales and, as the earlier cases against Warner-Chilcott and Insys show, pharmaceutical companies have an incentive to overcome those requirements, sometimes by fraud. [read post]
25 Aug 2021, 7:44 pm
” The post Appeals Court Affirms All Convictions of Insys Executives appeared first on Newman & Shapiro. [read post]
10 Jun 2021, 12:35 pm
Howard Hoffberg said he received $66,600 from Insys Therapeutics Inc. in exchange for ... [read post]
15 Apr 2021, 11:48 am
Insys Therapeutics, Case No. 1:19-cr-10191-RWZ (D. [read post]
24 Mar 2021, 1:25 pm
The launch coincides with the universities’ efforts to house more than 250,000 documents produced by opioid manufacturer Insys in the course of its bankruptcy proceedings following opioid litigation.The archive is similar to the groundbreaking Truth Tobacco Industry Documents archive at UCSF, which has fostered scientific and public health discoveries shaping tobacco policy in the U.S. and around the world. [read post]
2 Mar 2021, 3:39 pm
Attorney’s Office in the District of Massachusetts; Executives and managers of Insys Therapeutics, a pharmaceutical company, including its CEO and National Director of Sales, charged with violation of RICO as well as wire fraud, mail fraud, and conspiracy to violate the Anti-Kickback Law; see, Pharmaceutical Executives Charged in Racketeering Scheme, December 8, 2016, by the U.S. [read post]
27 Jan 2021, 5:55 am
Kapoor to pay NJ millions for deceptive Subsys marketing. [read post]
21 Jan 2021, 10:26 am
Kapoor, the founder of Insys Therapeutics (“Insys”), to resolve allegations that Kapoor orchestrated bribes to doctors in New Jersey as part of a nationwide kickback scheme to boost sales of Insys’ opioid drug known... [read post]
8 Sep 2020, 8:41 am
Consumers have long been calling for pharmaceutical companies to be held accountable for the ways in which they allegedly encourage doctors to prescribe opioids, so it should come as no surprise that the Arizona state attorney general’s office also pursued legal action against executives of various pharmaceutical companies, including Insys Therapeutics. [read post]
14 Feb 2020, 11:25 am
The government alleged that PSI worked with pharmaceutical companies – Insys, Aegerion, and Alexion – to design and operate three distinct funds that diverted money from the drug manufacturers to Medicare patients only taking drugs they sold. [read post]
